Highbridge Capital Management’s AngioDynamics ANGO Stock Holding History

Highbridge Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-18,388	Closed	-$305K	–	1166
2017 Q4	$305K	Sell	18,388 -6,916	-27%	-$118K	0.01%	1229
2017 Q3	$432K	Buy	25,304 +4,461	+21%	+$74.9K	0.01%	1014
2017 Q2	$338K	Sell	20,843 -3,302	-14%	-$52.2K	0.01%	924
2017 Q1	$419K	Buy	+24,145	New	+$404K	0.01%	982
2016 Q4	–	Sell	-11,028	Closed	-$193K	–	1233
2016 Q3	$193K	Buy	+11,028	New	+$179K	﹤0.01%	1187
2016 Q1	–	Sell	-23,456	Closed	-$285K	–	1460
2015 Q4	$285K	Sell	23,456 -2,244	-9%	-$27.6K	﹤0.01%	1209
2015 Q3	$339K	Buy	+25,700	New	+$388K	0.01%	1189
2014 Q3	–	Sell	-13,592	Closed	-$222K	–	1190
2014 Q2	$222K	Buy	+13,592	New	+$197K	﹤0.01%	946
2014 Q1	–	Sell	-15,726	Closed	-$269K	–	1029
2013 Q4	$269K	Buy	+15,726	New	+$242K	﹤0.01%	878

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Highbridge Capital Management's ANGO Position: Q1 2018 in Review

Highbridge Capital Management sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 18,388 shares — an estimated $305K sold.

Highbridge Capital Management first reported a position in ANGO in Q4 2013 and held it in 9 quarters. The position peaked at $432K in Q3 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

Highbridge Capital Management reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
Highbridge Capital Management sold 18,388 AngioDynamics shares in Q1 2018, an estimated $305K.
Highbridge Capital Management first reported a position in AngioDynamics in Q4 2013 and held it in 9 quarters.
Highbridge Capital Management's AngioDynamics position peaked at $432K in Q3 2017.
164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on Highbridge Capital Management's 13F filing for Q1 2018, filed 15 May 2018.